Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Den Ny Tids SundhedsParadigme ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   23.6% 15.6% 17.5% 11.2% 13.8% 19.0% 20.2% 20.2%   Credit score (0-100)   4 13 9 20 15 6 6 6   Credit rating   B BB B BB BB B B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   276 900 1,085 1,121 1,036 1,132 0.0 0.0   EBITDA   -45.0 32.0 153 83.0 -221 18.3 0.0 0.0   EBIT   -50.0 23.0 144 74.0 -230 13.8 0.0 0.0   Pre-tax profit (PTP)   -53.0 21.0 144.0 73.6 -230.8 15.2 0.0 0.0   Net earnings   -41.0 15.0 110.0 54.8 -181.7 7.7 0.0 0.0   Pre-tax profit without non-rec. items   -53.0 21.0 144 73.6 -231 15.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   9.0 24.0 135 190 7.9 15.6 -34.4 -34.4   Interest-bearing liabilities   14.0 34.0 0.0 0.5 51.3 0.3 34.4 34.4   Balance sheet total (assets)   186 188 607 484 276 261 0.0 0.0   Net Debt   -56.0 -51.0 -377 -390 -101 -159 34.4 34.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   276 900 1,085 1,121 1,036 1,132 0.0 0.0   Gross profit growth   0.0% 226.1% 20.6% 3.3% -7.6% 9.2% -100.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   186 188 607 484 276 261 0 0   Balance sheet change%   0.0% 1.1% 222.9% -20.2% -43.0% -5.4% -100.0% 0.0%   Added value   -45.0 32.0 153.0 83.0 -220.9 18.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   35 -18 -18 -18 -18 -9 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -18.1% 2.6% 13.3% 6.6% -22.2% 1.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -26.9% 12.3% 36.2% 13.7% -60.2% 5.7% 0.0% 0.0%   ROI %   -217.4% 56.8% 149.2% 45.8% -183.8% 40.8% 0.0% 0.0%   ROE %   -455.6% 90.9% 138.4% 33.8% -184.0% 65.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   4.8% 12.8% 22.2% 39.1% 2.9% 6.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   124.4% -159.4% -246.4% -469.6% 45.6% -868.5% 0.0% 0.0%   Gearing %   155.6% 141.7% 0.0% 0.2% 651.0% 2.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   42.9% 8.3% 0.0% 391.7% 6.6% 0.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.0 1.2 1.5 0.9 1.0 0.0 0.0   Current Ratio   0.8 1.0 1.2 1.5 0.9 1.0 0.0 0.0   Cash and cash equivalent   70.0 85.0 377.0 390.1 152.2 159.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -31.0 -7.0 113.0 158.1 -14.6 -2.4 -17.2 -17.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 32 153 83 -221 18 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 32 153 83 -221 18 0 0   EBIT / employee   0 23 144 74 -230 14 0 0   Net earnings / employee   0 15 110 55 -182 8 0 0